EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors

Ahmed M Elshazly iD, David A Gewirtz iD

International Journal of Molecular Sciences · 11.08.2023 · 24 (16) · 12669

DOI: 10.3390/ijms241612669 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.08.2023. Verfasst von Ahmed M Elshazly und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Massey Cancer Center, Virginia Commonwealth University, 401 College St., Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Cytostatic Agents, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Defense Congressionally Directed Breast Cancer Research Program, National Cancer Institute/National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bromodomain and extra-terminal domain (BET) family inhibitors are small molecules that target the dysregulated epigenetic readers, BRD2, BRD3, BRD4 and BRDT, at various transcription-related sites, including super-enhancers. BET inhibitors are currently under investigation both in pre-clinical cell culture and tumor-bearing animal models, as well as in clinical trials. However, as is the case with other chemotherapeutic modalities, the development of resistance is likely to constrain the therapeutic benefits of this strategy. One tumor cell survival mechanism that has been studied for decades is autophagy. Although four different functions of autophagy have been identified in the literature (cytoprotective, cytotoxic, cytostatic and non-protective), primarily the cytoprotective and cytotoxic forms appear to function in different experimental models exposed to BET inhibitors (with some evidence for the cytostatic form). This review provides an overview of the cytoprotective, cytotoxic and cytostatic functions of autophagy in response to BET inhibitors in various tumor models. Our aim is to determine whether autophagy targeting or modulation could represent an effective therapeutic strategy to enhance the response to these modalities and also potentially overcome resistance to BET inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytostatic AgentsAntineoplastic AgentsAnimalsNuclear ProteinsTranscription FactorsAutophagy

Stichwörter der Autor:innen

BET familyBRD4autophagycytoprotectivecytotoxicsenescence

Substanzen

Cytostatic AgentsNuclear ProteinsTranscription FactorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Massey Cancer Center, Virginia Commonwealth University, 401 College St., Richmond, VA 23298, USA.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.

ORCID-Profile: Ahmed M Elshazly, David A Gewirtz

Förderung

  • Department of Defense Congressionally Directed Breast Cancer Research Program
  • National Cancer Institute/National Institutes of Health

Zitieren

APA

Elshazly, A. M., & Gewirtz, D. A. (2023). Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors. International Journal of Molecular Sciences, 24(16), 12669. https://doi.org/10.3390/ijms241612669

Vancouver

Elshazly AM, Gewirtz DA. Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors. International Journal of Molecular Sciences. 2023;24(16):12669. doi:10.3390/ijms241612669

BibTeX
@article{Elshazly2023,
  author = {Elshazly, Ahmed M and Gewirtz, David A},
  title = {Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {16},
  pages = {12669},
  doi = {10.3390/ijms241612669}
}
Kostenlos starten →